{"id":1416,"date":"2026-02-20T13:00:53","date_gmt":"2026-02-20T13:00:53","guid":{"rendered":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/20\/ms-patients-see-lasting-benefits-from-briumvi-treatment-study-says\/"},"modified":"2026-02-20T13:00:53","modified_gmt":"2026-02-20T13:00:53","slug":"ms-patients-see-lasting-benefits-from-briumvi-treatment-study-says","status":"publish","type":"post","link":"https:\/\/wickedsister.evit.com.au\/index.php\/2026\/02\/20\/ms-patients-see-lasting-benefits-from-briumvi-treatment-study-says\/","title":{"rendered":"MS patients see lasting benefits from Briumvi treatment, study says"},"content":{"rendered":"<p><a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/20\/ms-patients-see-lasting-benefits-briumvi-treatment-study-says\/\" title=\"MS patients see lasting benefits from Briumvi treatment, study says\" rel=\"nofollow\"><img loading=\"lazy\" decoding=\"async\" width=\"800\" height=\"534\" src=\"https:\/\/multiplesclerosisnewstoday.com\/wp-content\/uploads\/2026\/02\/iStock-2219406924-800x534.jpg\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"A doctor puts medicine into an IV drip.\" style=\"margin: auto;margin-bottom: 15px;max-width: 100%\" data-wp-pid=\"159597\" \/><\/a><\/p>\n<p>Continued treatment with TG Therapeutics\u2019 Briumvi (ublituximab) provides sustained clinical benefits for people with relapsing forms of multiple sclerosis (MS), particularly if started earlier. That\u2019s according to data from the ULTIMATE I (NCT03277261) and ULTIMATE II (NCT03277248) Phase 3 clinical trials and their ongoing open-label extension (NCT04130997). After five years of follow-up, more than 80% [&#8230;]<\/p>\n<p>The post <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/20\/ms-patients-see-lasting-benefits-briumvi-treatment-study-says\/\">MS patients see lasting benefits from Briumvi treatment, study says<\/a> appeared first on <a href=\"https:\/\/multiplesclerosisnewstoday.com\">Multiple Sclerosis News Today<\/a>.<\/p>\n<p><em>Source: <a href=\"https:\/\/multiplesclerosisnewstoday.com\/news-posts\/2026\/02\/20\/ms-patients-see-lasting-benefits-briumvi-treatment-study-says\/\" rel=\"nofollow noopener\" target=\"_blank\">multiplesclerosisnewstoday.com<\/a><\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Continued treatment with TG Therapeutics\u2019 Briumvi (ublituximab) provides sustained clinical benefits for people with relapsing forms of multiple sclerosis (MS), particularly if started earlier. That\u2019s according to data from the ULTIMATE I (NCT03277261) and ULTIMATE II (NCT03277248) Phase 3 clinical trials and their ongoing open-label extension (NCT04130997). After five years of follow-up, more than 80%&#8230;<\/p>\n","protected":false},"author":0,"featured_media":1417,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[11,15,9,8,13,14,12,10],"class_list":["post-1416","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-multiple-sclerosis-research","tag-brain-repair","tag-marburg-type-ms","tag-ms","tag-multiple-sclerosis","tag-myelin","tag-neuroregeneration","tag-oligodendrocyte","tag-remyelination"],"_links":{"self":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1416","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/comments?post=1416"}],"version-history":[{"count":0,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/posts\/1416\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media\/1417"}],"wp:attachment":[{"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/media?parent=1416"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/categories?post=1416"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wickedsister.evit.com.au\/index.php\/wp-json\/wp\/v2\/tags?post=1416"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}